Measuring patient-reported outcomes in haemophilia clinical research

Haemophilia

Volumn 15, Issue 4, 2009, Pages 843-852

  Globe, Dennis ^a   Young, N L ^b   Von Mackensen, S ^c   Bullinger, M ^c   Wasserman, J ^d   Blanchette, Victor S ^e   Aledort, Louis M ^e   Ljung, Rolf ^e   van den Berg, Marijke ^e   Feldman, Brian M ^e   Gringeri, Alessandro ^e   Manco Johnson, Marilyn ^e   Petrini, Pia ^e   Rivard, Georges E ^e   Schramm, Wolfgang ^e  

^a AMGEN INC   (United States)

^b LAURENTIAN UNIVERSITY   (Canada)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF TEXAS   (United States)

^e NONE

Author keywords

Factor VIII; Haemophilia; Health status; Primary prophylaxis; Quality of life; Utility

Indexed keywords

CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CLINICAL RESEARCH; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HEALTH STATUS; HEMOPHILIA; HUMAN; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PEDIATRICS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESEARCH PRIORITY; REVIEW; SELF REPORT;

BIOMEDICAL RESEARCH; HEMARTHROSIS; HEMOPHILIA A; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 67649876352     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01961.x     Document Type: Review

References (56)

1. Szende A, Schramm W, Flood E et al. Health-related quality of life assessment in adult haemophilia patients: A systematic review and evaluation of instruments. Haemophilia 2003; 9: 678-87.
2. Remor E, Young N, VonMackensen S, Lopatina E. Disease-specific quality-of-life measurement tools for haemophilia patients. Haemophilia 2004; 10(Suppl. 4): 30-4.
3. Fischer K, Bom Jvd, Mauser-Bunschoten E, Roosendaal G, Berg HM. Effects of haemophilic arthropathy on health-related quality of life and socio-economic parameters. Haemophilia 2005; 11: 43-8.
4. Szabo S, on botWg. The World Health Organization Quality of Life (WHOQOL) assessment instrument. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia: Lippincott-Raven, 1996: 355-62.
5. Bullinger M. Quality of life-definition, conceptualization and implications -a methodologists view. Thero Surg 1991; 6: 143-9.
6. Bowling A. Measuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales, 2nd edn. Buckingham: Open University Press, 2001.
7. Revicki D, Gnanasakthy A, Weinfurt K. Documenting the rationale and psychometric characteristics of patient reported outcomes for labelling and promotional claims: The PRO evidence dossier. Qual Life Res 2007; 16: 717-23.
8. Feinstein A. Multiterm "instruments" versus Virginia Apgar's principles of clinimetrics. Arch Inter Med 1999; 159: 125-8.
9. Apolone G, Carli GD, Brunettie M, Garattini S. Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval. Pharmacoeconomics 2001; 19: 187-95.
10. Torrance G. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1-30.
11. Bennett K, Torrance G. Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia: Lippincott-Raven, 1996: 253-65.
12. Lohr K, Aaronson N, Burnam M, Patrick D, Perrin E, Robers J. Evaluating quality-of-life and health status instruments: Development of scientific review criteria. Clin Ther 1996; 18: 979-92.
13. Patrick D, Mathias S, Elkin E, Fifer S, Buesching D. Health state preferences of persons with anxiety. Int J Technol Assess Health Care 1998; 14: 357-71.
14. Gold M, Franks P, McCoy K, Fryback D. Towards a consistency in cost-utility analyses: Using national measures to create condition-specific values. Med Care 1998; 36: 778-92.
15. Torrance G. Social preferences for health states: An economic evaluation of three measurement techniques. Socioecon Plann Sci 1976; 10: 129-36.
16. Aday L. Designing and Conducting Health Surveys, 2nd edn. San Francisco: Jossey-Bass Inc., 1996.
17. Streiner D, Norman G. Health Measurement Scales: A Practical Guide to Their Development and Use, 2nd edn. New York: Oxford University Press, 1998.
18. Beeton K. Evaluation of outcome of care in patients with haemophilia. Haemophilia 2002; 8: 428-34.
19. De KP, Heijnen L, Van MN. Clinimetric instruments to assess functional health status in patients with haemophilia: A literature review. Haemophilia 2002; 8: 419-27.
20. Fischer K, van der Bom J, van den Berg H. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia 2003; 9(Suppl. 1): 75-81.
21. Von Mackensen S. Quality of life and sports activities in patients with haemophilia. Haemophilia 2007; 13(Suppl. 2): 38-43.
22. Arranz P, Remor E, Quintana M et al. Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia 2004; 10: 376-82.
23. von MS, Gringeri A, Santoni L et al. Development and pilot testing of a disease-specific quality of life questionnaire for adult patients with haemophilia (Haem-A-QoL). Blood 2004; 104: 2214.
24. Gringeri A, Mantovani L, von MS. Quality of life assessment in clinical practice in haemophilia treatment. Haemophilia 2006; 12(Suppl. 3): 1-8.
25. Guerois C, Lambert T, Peynet J, Fressinaud E, Chambost H, Trudeau E. Assessment of quality of life in hemophilia population: Validation of the QUAL-HEMO, a French haemophilia age-group specific quality of life questionnaire. Haemophilia 2006; 12(Suppl. 2): 121-5 (abstract number P0804).
26. Flood E, Szende A, Rentz A et al. Health-related quality of life in adults with hemophilia: The patient perspective. J Thromb Haemost 2003; 1(Suppl. 1): 25 (abstract number P0657).
27. Rentz A, Flood E, Altisent C et al. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia. Haemophilia 2008; 14: 1023-34.
28. Remor E, Arranz P, Quintana M et al. Psychometric field study of the new haemophilia quality of life questionnaire for adults: The 'Hemofilia-QoL. Haemophilia 2005; 11: 603-10.
29. Landgraf J, Maunse E, Speechley K et al. Canadian-French, German and UK versions of the Child Health Questionnaire: Methodology and preliminary item scaling results. Qual Life Res 1998; 7: 433-45.
30. Ravens-Sieberer U, Erhart M, Wille N, Wetzel R, Nickel J, Bullinger M. Generic health-related quality of life assessment in children and adolescents: Methodological considerations. Pharmacoeconomics 2006; 24: 1198-220.
31. Torrance G, Boyle M, Horwood S. Application of multi-attribute utility theory to measure social preference for health states. Oper Res 1982; 30: 1043-69.
32. Young N, Bradley C, Wakefield C, Barnard D, Blanchette V, McCusker P. How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia. Pediatr Blood Cancer 2006; 47: 305-11.
33. Bullinger M, von MS, Fischer K et al. Pilot testing of the 'Haemo-QoL' quality of life questionnaire for haemophiliac children in six European countries. Haemophilia 2002; 8(Suppl. 2): 47-54.
34. VonMackensen S, Bullinger M, Haemo-QoL Group. Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL). Haemophilia 2004; 10(Suppl. 1): 17-25.
35. Pollak E, Mühlan H, von MS, Bullinger M, H-QG. The Haemo-QoL Index: developing a short measure for health-related quality of life assessment in children and adolescents with haemophilia. Haemophilia 2006; 12: 384-92.
36. Young N, Bradley C, Blanchette V et al. Development of a health-related quality of life measure for boys with haemophilia: The Canadian Haemophilia Outcomes - Kids Life Assessment Tool (CHO-KLAT). Haemophilia 2004; 10(Suppl. 1): 34-43.
37. Manco-Johnson M, Morrissey-Harding G, Edelman-Lewis B, Oster G, Larson P. Development and validation of a measure of disease-specific quality of life in young children with haemophilia. Haemophilia 2004; 10: 34-41.
38. Feeny D, Torrance G, Furlong W. Health utilities index. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia: Lippincott-Raven, 1996: 239-52.
39. Miners A, Sabin C, Tolley K, Jenkinson C, Kind P, Lee C. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999; 5: 378-85.
40. Brooks R, Group E. EuroQol: The current state of play. Health Policy 1996; 37: 53-72.
41. Wasserman J, Aday L, Begley C, Ahn C, Lairson D. Measuring health state preferences for haemophilia: Development of a disease-specific utility instrument. Haemophilia 2005; 11: 49-57.
42. Barr R, Saleh M, Furlong W et al. Health status and health-related quality of life associated with haemophilia. Am J Hematol 2002; 71: 152-60.
43. Wang T, Zhang L, Li H, Zhao H, Yang R. Assessing health-related quality-of-life in individuals with haemophilia in China. Haemophilia 2004; 10: 370-5.
44. Barr R, Sek J, Horsman J et al. Health status and health-related quality of life associated with von Willebrand disease. Am J Hematol 2003; 73: 108-14.
45. Gringeri A, Mantovani L, Scalone L, Mannucci P, Group. CS. Cost of care and quality of life for patients with haemophilia complicated by inhibitors: The COCIS Study Group. Blood 2003; 102: 2358-63.
46. Revel-Vilk S, Golomb M, Achonu C et al. Effect of intracranial bleeds on the health and quality of life of boys with haemophilia. J Peds 2004; 144: 490-5.
47. Torrance G, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions. Health utilities index. Pharmacoeconomics 1995; 7: 503-20.
48. Larners L. The transformation of utilities for health states worse than death: Consequences for the estimation of EQ-5D value sets. Med Care 2007; 45: 238-44.
49. Coons S, Rao S, Keininger D, Hays R. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000; 17: 13-35.
50. Gold M, Siegel J, Russell L, Weinstein M. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
51. Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 health survey. J Clin Epidemiol 1998; 51: 1115-28.
52. Fryback D, Lawrence W, Martin P, Klein R, Klein B. Predicting quality of well-being scores from the SF-36: Results from the Beaver Dam Health Outcomes Study. Med Dec Making 1997; 17: 1-9.
53. Walsh M, Macgregor D, Stuckless S, Barrett B, Kawaja M, Scully M-F. Health-related quality of life in a cohort of adult patients with mild hemophilia A. J Thromb Haemost 2008; 6: 755-61.
54. Varni J, Burwinkle T, Seid M. The PedsQL as a pediatric patient-reported outcome: Reliability and validity of the PedsQL measurement model in 25,000 children. Expert Rev Pharmacoec Outcomes Res 2005; 5: 705-19.
55. Bullinger M, von MS, Haemo-QoL G. Quality of life in children and families with bleeding disorders. J Pediatr Hematol Oncol 2003; 25: S64-7.
56. Sung L, Young N, Greenberg M et al. Health related quality of life (HRQL) scores reported from parents and their children with chronic illness differed depending on utility elicitation method. J Clin Epidemiol 2004; 57: 1161-6.